Veracyte [VCYT] vs Revvity [RVTY] Detailed Stock Comparison

Veracyte Inc.

NASDAQ
Loading...

Revvity Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Veracyte Inc. wins in 10 metrics, Revvity Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Veracyte Inc. Revvity Inc. Better
P/E Ratio (TTM) 40.43 45.77 Veracyte Inc.
Price-to-Book Ratio 2.01 1.46 Revvity Inc.
Debt-to-Equity Ratio 3.03 46.87 Veracyte Inc.
PEG Ratio 0.06 3.92 Veracyte Inc.
EV/EBITDA 26.79 15.48 Revvity Inc.
Profit Margin (TTM) 12.83% 8.45% Veracyte Inc.
Operating Margin (TTM) 17.50% 20.07% Revvity Inc.
EBITDA Margin (TTM) 17.50% 20.07% Revvity Inc.
Return on Equity 5.34% 3.22% Veracyte Inc.
Return on Assets (TTM) 2.91% 2.22% Veracyte Inc.
Free Cash Flow (TTM) $126.63M $509.41M Revvity Inc.
Dividend Yield N/A 0.25% N/A
1-Year Return 74.15% 15.63% Veracyte Inc.
Price-to-Sales Ratio (TTM) 5.11 3.69 Revvity Inc.
Enterprise Value $2.26B $13.02B Revvity Inc.
EV/Revenue Ratio 4.37 4.56 Veracyte Inc.
Gross Profit Margin (TTM) 72.51% 54.62% Veracyte Inc.
Revenue per Share (TTM) $7 $25 Revvity Inc.
Earnings per Share (Diluted) $0.82 $2.06 Revvity Inc.
Beta (Stock Volatility) 1.96 1.13 Revvity Inc.
Short % of Float 8.87% 11.04% Veracyte Inc.

Veracyte Inc. vs Revvity Inc. Stock Performance Analysis

Loading Price Chart...

VCYT
RVTY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Veracyte Inc.1.88%9.46%45.59%38.83%1.99%14.89%
Revvity Inc.0.68%4.42%16.83%5.34%-2.12%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Veracyte Inc.74.15%73.43%40.68%774.34%276.75%276.75%
Revvity Inc.15.63%-9.26%-24.76%91.55%296.02%399.05%

Performance & Financial Health Analysis: Veracyte Inc. vs Revvity Inc.

MetricVCYTRVTY
Market Information
Market Cap i$2.74B$9.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i744,389860,236
90 Day Avg. Volume i891,963959,002
Last Close$48.70$101.07
52 Week Range$22.61 - $50.71$81.22 - $118.30
% from 52W High-3.96%-14.56%
All-Time High$86.03 (Feb 08, 2021)$203.16 (Dec 27, 2021)
% from All-Time High-43.39%-50.25%
Growth Metrics
Quarterly Revenue Growth0.19%0.06%
Quarterly Earnings Growth7.05%0.04%
Financial Health
Profit Margin (TTM) i0.13%0.08%
Operating Margin (TTM) i0.18%0.20%
Return on Equity (TTM) i0.05%0.03%
Debt to Equity (MRQ) i3.0346.87
Cash & Liquidity
Book Value per Share (MRQ)$16.50$64.57
Cash per Share (MRQ)$5.20$8.23
Operating Cash Flow (TTM) i$136.31M$582.93M
Levered Free Cash Flow (TTM) i$86.80M$523.28M
Dividends
Last 12-Month Dividend Yield iN/A0.25%
Last 12-Month Dividend iN/A$0.28

Valuation & Enterprise Metrics Analysis: Veracyte Inc. vs Revvity Inc.

MetricVCYT (Apr 26, 2026)RVTY (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i40.4345.77
Forward P/E i18.8015.70
PEG Ratio i0.063.92
Price to Sales (TTM) i5.113.69
Price to Book (MRQ) i2.011.46
Market Capitalization
Market Capitalization i$2.74B$9.74B
Enterprise Value i$2.26B$13.02B
Enterprise Value Metrics
Enterprise to Revenue i4.374.56
Enterprise to EBITDA i26.7915.48
Risk & Other Metrics
Beta i1.961.13
Book Value per Share (MRQ) i$16.50$64.57

Financial Statements Comparison: Veracyte Inc. vs Revvity Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVCYT (2025)RVTY (2025)
Revenue/Sales i517.15M2.86B
Cost of Goods Sold i154.61M1.29B
COGS % of Revenue i29.9%45.2%
Gross Profit i362.53M1.56B
Gross Margin i70.1%54.8%
Research & Development i70.81M215.84M
Operating Income (EBIT) i78.28M356.64M
Operating Margin i15.1%12.5%
EBITDA i112.86M792.21M
EBITDA Margin i21.8%27.7%
Pre-Tax Income i68.20M268.28M
Pre-Tax Income % of Revenue i13.2%9.4%
Income Tax i1.85M28.39M
Income Tax % of Revenue i0.4%1.0%
Net Income (Profit) i66.35M241.20M
Profit Margin i12.8%8.4%

Balance Sheet & Liquidity Metrics

MetricVCYT (2025)RVTY (2025)
Cash & Equivalents i362.58M919.86M
Total Current Assets i488.38M2.24B
Total Current Assets % of Revenue i94.4%78.4%
Total Current Liabilities i59.94M1.33B
Total Current Liabilities % of Revenue i11.6%46.6%
Long-Term Debt i35.60M2.78B
Long-Term Debt % of Revenue i6.9%97.3%
Total Shareholders Equity i1.31B7.25B
Retained Earnings i-377.63M6.05B
Retained Earnings % of Revenue i-73.0%212.0%
Property, Plant & Equipment i73.32M165.44M

Cash Flow Statement Comparison

MetricVCYT (2025)RVTY (2025)
Operating Cash Flow i111.92M586.69M
Operating Cash Flow % of Revenue i21.6%20.5%
Capital Expenditures i-9.68MN/A
Free Cash Flow i126.63M509.41M
FCF Margin i24.5%17.8%
Debt Repayment iN/A-521,000
Common Stock Repurchase iN/A-820.82M

Short Interest & Institutional Ownership Analysis

MetricVCYTRVTY
Shares Short i6.33M8.24M
Short Ratio i5.897.79
Short % of Float i8.87%11.04%
Shares Outstanding i79.36M112.28M
Float Shares i79.02M102.65M
% Held by Insiders i1.00%0.34%
% Held by Institutions i110.26%103.68%
% Held by Public i-11.26%-4.02%

Dividend Analysis & Yield Comparison: Veracyte Inc. vs Revvity Inc.

MetricVCYTRVTY
Last 12-Month Dividend iN/A$0.28
Last 12-Month Dividend Yield iN/A0.25%
3-Year Avg Annual Dividend iN/A$0.28
3-Year Avg Dividend Yield iN/A0.06%
3-Year Total Dividends iN/A$0.84
Ex-Dividend DateN/AJan 16, 2026